Suppr超能文献

[冯·希佩尔-林道(VHL)肿瘤抑制基因的频繁体细胞突变及其在散发性人类肾透明细胞癌中的意义]

[Frequent somatic mutations of the von Hippel-Lindau (VHL) tumor suppressor gene and its meaning in sporadic human renal clear cell carcinoma].

作者信息

Gong Kan, Zhang Ning, Guo Hong-feng, Zhang Zhi-wen, Xin Dian-qi, Na Yan-qun

机构信息

Department of Urology, Peking University First Hospital, Beijing 100034, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2004 Apr;36(2):169-72.

Abstract

OBJECTIVE

To investigate the mutation of VHL gene, an important tumor suppressor gene in primary sporadic human renal cell carcinoma (RCC) and analyse its relationships with pathological stage and grade of renal cell carcinoma.

METHODS

We analyzed 57 cases of primary sporadic Chinese renal clear carcinoma using the polymerase chain reaction (PCR) and denaturing high performance liquid chromatography(DHPLC). All positive cases in DHPLC analysis were further characterized by direct sequencing.

RESULTS

Somatic mutations were detected in 30 (53%) of 57 clear cell renal carcinomas including 13 deletions, 2 insertions, and 15 missense mutations. These mutations mainly occurred in the last one-third region of exon 1, 2,and 3.

CONCLUSION

VHL tumor suppressor gene is one of the major tumor suppressor genes in human renal cell carcinoma and there are frequent mutations of VHL in primary sporadic Chinese renal clear cell carcinomas. The mutations of VHL gene were irrespective of the age and pathological grade and stage of patients.

摘要

目的

研究人类原发性散发性肾细胞癌(RCC)中重要的肿瘤抑制基因VHL基因的突变情况,并分析其与肾细胞癌病理分期及分级的关系。

方法

我们采用聚合酶链反应(PCR)和变性高效液相色谱法(DHPLC)分析了57例中国原发性散发性肾透明细胞癌病例。DHPLC分析中的所有阳性病例均通过直接测序进一步鉴定。

结果

在57例透明细胞肾细胞癌中,有30例(53%)检测到体细胞突变,其中包括13例缺失、2例插入和15例错义突变。这些突变主要发生在外显子1、2和3的最后三分之一区域。

结论

VHL肿瘤抑制基因是人类肾细胞癌中的主要肿瘤抑制基因之一,在中国原发性散发性肾透明细胞癌中VHL基因存在频繁突变。VHL基因突变与患者的年龄、病理分级及分期无关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验